Join us at the FTC!
Displaying 41 - 60 of 177
Joint Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, Regarding the Health Breach Notification Rule
Regarding the Health Breach Notification Rule
Date
Matter Number
P205405
By
Related Releases
Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, Regarding the FTC Collaboration Act Report
Regarding the FTC Collaboration Act Report
Date
Matter Number
P234800
By
Remarks by Chair Lina M. Khan As Prepared for Delivery at the Private Capital, Public Impact Workshop on Private Equity in Healthcare
Date
By
Lina M. Khan, Commissioner
Related Releases
Letter from Chair Khan to Rep. Jim Jordan, Chairman of the House Judiciary Committee, Regarding the FTC's Investigation of Potential Third-Party Access to the Information of Twitter Users
Regarding the FTC's Investigation of Potential Third-Party Access to the Information of Twitter Users
Date
Matter Number
P210100
By
Lina M. Khan, Commissioner
Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, Regarding the Final Trade Regulation Rule on Impersonation of Government and Businesses
Regarding the Final Trade Regulation Rule on Impersonation of Government and Businesses
Washington, D.C.
Date
Matter Number
R207000
By
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress
Date
Matter Number
P110014
By
Lina M. Khan, Commissioner
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics
Date
Matter Number
D09422
By
Lina M. Khan, Commissioner;
Rebecca Kelly Slaughter, Commissioner
File
Text of Statement
(126.92 KB)
Letter From Chair Khan to Rep. Tiffany Regarding Merger Challenges
Date
By
Lina M. Khan, Commissioner
File
File
Appendix A - FTC Merger Â鶹´«Ã½
(134.79 KB)
Displaying 41 - 60 of 177